Skip to main content
. Author manuscript; available in PMC: 2023 Jun 28.
Published in final edited form as: Arch Microbiol Immunol. 2023 Mar 17;7(1):18–28. doi: 10.26502/ami.936500101

Table 3:

Combined expression of GATA3 and mammaglobin in luminal and triple negative breast tumors from African American women

Luminal Tumors Triple negative tumors
+ Sensitivity + Sensitivity
GATA3 positive 108 3 97% 14 48 23%
Mammaglobin positive 70 40 64% 30 33 48%
GATA3 negative and mammaglobin negative 1 28 3% 22 7 76%
GATA3 positive and mammaglobin positive 63 10 86% 5 68 7%
Either GATA3 or mammaglobin positive 42 39 52% 34 46 43%